Genzyme, Sanofi boards meet to clinch $20 billion deal
(Reuters)
Unusual Little Blurbs
Reuters - Sanofi-Aventis SA is close to clinching a deal worth around $20 billion to buy Genzyme Corp, nearly nine months after the French drugmaker first put the idea to the U.S. biotech group.